11/30/23 16:05 | 11/28/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 6 | 0.6486 | 0 | 10 | 25 | 50 | D | | | | | | | | | | | | | | |
11/22/23 16:06 | 11/21/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 6 | 0.6383 | 0 | 10 | 33 | 40 | D | | | | | | | | | | | | | | |
11/20/23 20:14 | 11/16/23 | JSPR | Jasper Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P.m | 18 | 0.6080 | 0 | 30 | New | 30 | D | | | | | | | | | | | | | | |
12/7/22 16:29 | 12/5/22 | PRDS | Pardes Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P | 14 | 1.09 | 0 | 13 | 33 | 50 | D | | | | | | | | | | | | | | |
12/5/22 16:21 | 12/1/22 | PRDS | Pardes Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P.m | 39 | 1.05 | 0 | 38 | New | 38 | D | | | | | | | | | | | | | | |
8/19/19 21:48 | 8/19/19 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P.d | 200 | 8.54 | 0 | 23 | 10 | 257 | D | | | | | | | | | | | | | | |
7/9/18 18:57 | 7/9/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 10.00 | 0 | 12 | 6 | 211 | D | | | | | | | | | | | | | | |
7/2/18 17:04 | 7/2/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 8.71 | 0 | 14 | 7 | 199 | D | | | | | | | | | | | | | | |
6/25/18 17:40 | 6/25/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 9.84 | 0 | 12 | 7 | 185 | D | | | | | | | | | | | | | | |
6/18/18 16:19 | 6/18/18 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 120 | 10.10 | 0 | 12 | 7 | 173 | D | | | | | | | | | | | | | | |
1/15/09 12:38 | 1/14/09 | PLI | Peplin Inc | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 5 | 10.00 | 0 | 1 | 0 | 228 | | | | | | | | | | | | | | | |
11/21/08 14:20 | 11/19/08 | PLI | Peplin Inc | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 2 | 3.95 | 0 | 1 | 0 | 227 | D | | | | | | | | | | | | | | |
11/12/08 13:14 | 11/10/08 | PLI | Peplin Inc | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO,CB | P | 3 | 6.00 | 0 | 1 | 0 | 227 | D | | | | | | | | | | | | | | |
8/30/07 13:48 | 8/29/07 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 39 | 38.67 | 33 | 1 | New | 1 | D | 97 | 166 | 52 | 29 | 43 | 17 | 16 | 15 | 1 | 12 | 12 | 42 | -29 | 5 |
10/2/06 17:32 | 10/2/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P | 43 | 10.75 | 0 | 4 | 1 | 299 | D | | | | | | | | | | | | | | |
9/22/06 13:57 | 9/21/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P | 21 | 10.64 | 0 | 2 | 1 | 295 | D | | | | | | | | | | | | | | |
9/20/06 17:09 | 9/19/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P.m | 43 | 10.76 | 0 | 4 | 1 | 293 | D | | | | | | | | | | | | | | |
2/9/04 21:53 | 2/6/04 | ABGX | Abgenix Inc | DE | Health | BioPrd | Biological Products, (No Diag | Wiggans Thomas G | CA | D | | P | 15 | 15.21 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |